Cannabis and Pregnancy Nausea

This article is for information only and is not medical advice. Talk to a doctor before using cannabis for a health condition, and do not stop or change prescribed treatment on your own.

Not Medical Advice

This article is informational only, not medical advice. Pregnancy is a context where decisions should involve your obstetric provider. If you are using cannabis during pregnancy or considering it, talk to your doctor—ideally someone you trust to be non-judgmental. Many pregnant people hesitate to disclose cannabis use because they fear legal or child welfare reporting. Reporting practices and legal protections vary by jurisdiction; however, undisclosed use prevents your clinician from providing appropriate prenatal care and monitoring. An honest conversation with your provider is safer than concealment.

Plain-Language Summary

Nausea and vomiting affect roughly 70–80% of pregnancies Strong evidence^[1]. A small proportion—0.3–3%—develop hyperemesis gravidarum (HG), severe and persistent vomiting that causes weight loss, dehydration, and sometimes hospitalization Strong evidence^[1].

Surveys consistently find that pregnant people who use cannabis most often cite nausea relief as a reason Weak / limited^[2][3]. In one US study, people with severe nausea were nearly four times more likely to use cannabis than those without Weak / limited^[2]. However, this is an association—it does not prove cannabis caused relief. People with severe nausea may differ from others in many ways (tobacco use, socioeconomic status, access to care), so causation cannot be assumed.

Here is the core tension: cannabis appears to reduce nausea for many users (consistent with its established effects in chemotherapy patients), but THC crosses the placenta, and prenatal exposure is associated with lower birth weight and possible neurodevelopmental concerns Strong evidence^[4][5]. The American College of Obstetricians and Gynecologists (ACOG) recommends against cannabis use in pregnancy Strong evidence^[6]. There are no randomized controlled trials of cannabis for pregnancy nausea or HG.

For a detailed overview of broader pregnancy risks, see Cannabis and Pregnancy: Risks and Evidence.

What Probably Works (in Non-Pregnancy Contexts)

Cannabis and isolated cannabinoids have strong evidence for reducing chemotherapy-induced nausea and vomiting (CINV). The National Academies' 2017 systematic review concluded that oral cannabinoids are effective antiemetics in that setting Strong evidence^[7]. Dronabinol and nabilone (synthetic THC analogs) are FDA-approved for chemotherapy nausea.

The proposed mechanism—CB1 receptor activity in brainstem emetic centers—is the same in principle for pregnancy nausea. So there is a plausible biological basis to expect cannabis might help Weak / limited.

However, efficacy in a different patient population does not transfer automatically to pregnancy. We have no randomized controlled trials of cannabis (smoked, vaped, or edible) for pregnancy nausea or HG. The supporting data come from surveys, which are vulnerable to recall bias, selection bias (people who benefit are more likely to report), and confounding. See Cannabis and Chemotherapy-Induced Nausea and Vomiting for details on the chemotherapy evidence.

What Might Work (Limited or Anecdotal Evidence in Pregnancy)

Self-reported symptom relief: In surveys of pregnant cannabis users, most report it relieves nausea, and some say it is more effective than prescribed antiemetics Weak / limited^[3]. This pattern appears across multiple studies but carries the well-known limitations of self-report: participants who benefit are more likely to participate and recall the benefit; people may conflate coincidence with causation; memory may be unreliable months or years later.

Hyperemesis gravidarum: Qualitative interviews and case descriptions document pregnant people with HG using cannabis after standard treatments failed Anecdote^[8]. None of these accounts are from controlled trials. Some people with HG report cannabis is the only intervention that allows them to keep food down; patient-advocacy communities take this seriously. However, anecdotal accounts do not establish efficacy, and absence of formal evidence does not mean the effect is absent.

CBD alone: Sometimes promoted as a 'safer' alternative to THC-dominant products. There is no good evidence that CBD reduces pregnancy nausea No data. The FDA has advised against CBD use in pregnancy based on animal reproductive-toxicity data, and contamination with THC is common in unregulated CBD products No data^[9].

What Doesn't Work or Has No Supporting Evidence

• The 'natural = safe' argument. Cannabis is a plant, but so are tobacco and alcohol. Plant origin says nothing about fetal safety No data.
• The 'historical use' argument. Historical cannabis use is not a controlled study. Modern cannabis products, especially high-concentration extracts, contain far more THC than historical cannabis and have no historical precedent No data.
• CBD-only products for pregnancy nausea. No human efficacy data exist. Unregulated CBD products frequently contain THC No data^[9].
• Specific strain or effect claims. Strain names do not reliably predict medical outcomes; the evidence does not support 'indica for nausea' or similar claims. See Cannabis and Nausea for more on this folklore No data.

Comparison with Standard Treatments

ACOG recommends a graduated approach for nausea and vomiting of pregnancy (NVP) Strong evidence^[6]:

1. Vitamin B6 (pyridoxine) ± doxylamine. First-line. Often sold in the US as Diclegis. Decades of safety data and clinical use Strong evidence^[6].
2. Ginger. Modest evidence for mild-to-moderate nausea; generally considered safe Weak / limited.
3. Antihistamines (dimenhydrinate, meclizine). Acceptable safety; modest efficacy Strong evidence.
4. Metoclopramide or promethazine. For more severe cases; well-studied in pregnancy Strong evidence.
5. Ondansetron. Effective; one study suggested a small increased risk of cleft palate, but others found no association. Current consensus: acceptable when benefits outweigh risks Disputed^[10].
6. Corticosteroids (methylprednisolone). Reserved for refractory HG, typically after 10 weeks, in hospitalized settings.
7. IV fluids and thiamine. Standard for severe HG; corrects dehydration and nutritional deficiency.

The essential difference: these alternatives have decades of accumulated safety data in pregnancy, established efficacy, and clear risk–benefit frameworks. Cannabis in pregnancy has none of these.

Fetal and Neonatal Risks of Prenatal Cannabis Exposure

Lower birth weight: Meta-analyses consistently find prenatal cannabis exposure is associated with reduced birth weight (roughly 100–110 g lower on average) and increased risk of NICU admission Strong evidence^[4][5]. This is one of the most replicated findings in the cannabis-pregnancy literature. However, this is observational evidence; unmeasured confounding (tobacco co-use, socioeconomic stress, other substance use) may partly explain the association.

Neurodevelopmental effects: Longitudinal cohort studies (Ottawa Prenatal Prospective Study, Generation R) report associations with attention deficits, impulsivity, and executive function problems in childhood Weak / limited^[11]. Effect sizes are modest, and confounding by socioeconomic status, tobacco co-use, and other substances remains difficult to fully remove. The causal pathway is uncertain.

Stillbirth: One large NIH-funded study found prenatal cannabis exposure associated with approximately 2.3-fold increased stillbirth risk Weak / limited^[12]. However, this study could not fully disentangle cannabis from tobacco co-use, which is itself a major independent risk factor for stillbirth. The cannabis-specific contribution remains unclear.

Preterm birth: Findings are mixed; some studies show modest increased risk, others do not Disputed^[4].

Cannabinoid hyperemesis syndrome: Heavy chronic cannabis use can paradoxically cause cyclic vomiting, which can mimic, complicate, or worsen HG Strong evidence. This is a serious risk for anyone using cannabis heavily while pregnant.

Breastfeeding: THC concentrates in breast milk and persists for days to weeks after use. The American Academy of Pediatrics advises against cannabis use while breastfeeding Strong evidence^[13]. Effects on breastfed infants have not been rigorously studied in controlled settings.

What We Don't Know

• Dose-response. Most pregnancy studies do not distinguish occasional from daily use, or low-THC from high-THC products. A single puff and daily concentrate use represent vastly different exposures; their fetal effects are likely different but have not been formally compared.
• Route of administration. Smoked, vaped, edible, and tincture forms likely differ in bioavailability and placental transfer kinetics, and probably in symptom relief. No comparative pregnancy data exist.
• CBD in pregnancy. Almost no human pregnancy data. Animal studies raise reproductive concerns (testicular and prostate effects in male offspring) but human relevance is unclear No data^[9].
• Whether cannabis helps HG specifically. No controlled trial. Given that HG can be life-threatening and some people do not respond to standard treatments, this is a genuine research gap.
• Confounding and causation. Pregnant cannabis users differ from non-users in tobacco use, socioeconomic status, mental health, and access to care. Untangling cannabis-specific fetal effects from these confounders remains difficult. Residual confounding almost certainly exists, and some reported associations may be correlational rather than causal Weak / limited^[4].

Bottom Line

Cannabis probably does relieve nausea for many pregnant people—the pharmacological mechanism is real and user reports are consistent. But 'works for symptoms' is not the same as 'safe for the fetus.' The fetal-exposure evidence, while imperfect and confounded, consistently points toward increased birth-weight reduction and possibly neurodevelopmental concerns.

The rational sequence is:

1. Start with vitamin B6 and doxylamine (Diclegis), which have strong, decades-long safety data.
2. Escalate through standard antiemetics (ginger, antihistamines, metoclopramide, ondansetron) with your obstetric provider's guidance based on severity.
3. For severe or refractory HG, discuss corticosteroids and inpatient IV hydration and nutritional support with your obstetric team.

If you are already using cannabis in pregnancy, tell your provider. Honest disclosure allows your clinician to monitor appropriately and manage your care in the context of full information. Your provider's responsibility is to help you and your baby—not to judge or report you without legal cause (though legal protections vary by jurisdiction).

Sources

How this page was made

Related

• Cannabis and Chemotherapy-Induced Nausea and Vomiting — Synthetic THC drugs treat refractory CINV, but modern antiemetics remain first-line. Smoke...
• Cannabis and Nausea — Cannabinoids reduce chemotherapy nausea; evidence is weak for other causes.
• Cannabis and Pregnancy: Risks and Evidence — Medical consensus against cannabis use in pregnancy based on fetal exposure and growth res...